Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: "Today's approval of pembrolizumab (Keytruda) in combination with...

25 May 2022

Breast Cancer Now has commented on new research published in Genetics in Medicine titled 'Breast cancer risk stratification in women of screening age...

23 May 2022

Catherine Priestley, Clinical Nurse Specialist at Breast Cancer Now, said: “With it estimated that around 35,000 people are living with secondary...

17 May 2022

New research, funded by Breast Cancer Now and Cancer Research UK at the universities of York and Cambridge, has show that analysing sodium levels in...

25 April 2022

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It's disappointing that NICE has provisionally been unable to approve...

1 April 2022

Commenting on research published in PLOS Medicine about artificial sweeteners and breast cancer risk, Dr Kotryna Temcinaite, Senior Research...

24 March 2022

On 16 March new findings from the OlympiA phase III trial were presented at a virtual plenary session from the European Society of Medical...

16 March 2022

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now said: “We welcome NHS England’s ambition to deliver more rapid cancer diagnosis -...

10 March 2022

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s alarming that in January, for the first time, less than half of women (...

10 March 2022